Search research articles
Contact Us
Filters
Showing results (141-150 of 161) with videos related to
Page
of 17
Sort By:
Frontiers in Dementia
|
May 22, 2024
Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women
Matilde Nerattini, Federica Rubino, Steven Jett, et al.
Plos One
|
January 13, 2025
Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's disease
Matilde Nerattini, Schantel Williams, Caroline Andy, et al.
Human Gene Therapy
|
May 14, 2008
Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA
Stefan Worgall, Dolan Sondhi, Neil R Hackett, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 11, 2013
Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter
Anat Maoz, Martin J Hicks, Shankar Vallabhjosula, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 7, 2025
Quantitative and simplified [18F] fluoroestradiol positron emission tomography (PET) measures of brain estrogen receptor expression
Matilde Nerattini, Valentina Berti, Dawn C Matthews, et al.
The Journal of Clinical Investigation
|
July 11, 2006
Possible axonal regrowth in late recovery from the minimally conscious state
Henning U Voss, Aziz M Uluğ, Jonathan P Dyke, et al.
Environmental Science and Pollution Research International
|
June 13, 2001
Dioxin contamination in food. Bayreuth, Germany, from September 28 to October 1, 2000
A Büchert, T Cederberg, P Dyke, et al.
Cancer Gene Therapy
|
December 16, 2014
Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma
Martin J Hicks, Kosuke Funato, Lan Wang, et al.
The Lancet. Neurology
|
December 15, 2023
Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study
Angela Schulz, Nicola Specchio, Emily de Los Reyes, et al.
Human Gene Therapy
|
August 25, 2023
Positron Emission Tomography Quantitative Assessment of Off-Target Whole-Body Biodistribution of I-124-Labeled Adeno-Associated Virus Capsids Administered to Cerebral Spinal Fluid
Jonathan B Rosenberg, Edward K Fung, Jonathan P Dyke, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 161) with videos related to
Sort By:
Page
of 17
Frontiers in Dementia
|
May 22, 2024
Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women
Matilde Nerattini, Federica Rubino, Steven Jett, et al.
Plos One
|
January 13, 2025
Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's disease
Matilde Nerattini, Schantel Williams, Caroline Andy, et al.
Human Gene Therapy
|
May 14, 2008
Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA
Stefan Worgall, Dolan Sondhi, Neil R Hackett, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 11, 2013
Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter
Anat Maoz, Martin J Hicks, Shankar Vallabhjosula, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 7, 2025
Quantitative and simplified [18F] fluoroestradiol positron emission tomography (PET) measures of brain estrogen receptor expression
Matilde Nerattini, Valentina Berti, Dawn C Matthews, et al.
The Journal of Clinical Investigation
|
July 11, 2006
Possible axonal regrowth in late recovery from the minimally conscious state
Henning U Voss, Aziz M Uluğ, Jonathan P Dyke, et al.
Environmental Science and Pollution Research International
|
June 13, 2001
Dioxin contamination in food. Bayreuth, Germany, from September 28 to October 1, 2000
A Büchert, T Cederberg, P Dyke, et al.
Cancer Gene Therapy
|
December 16, 2014
Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma
Martin J Hicks, Kosuke Funato, Lan Wang, et al.
The Lancet. Neurology
|
December 15, 2023
Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study
Angela Schulz, Nicola Specchio, Emily de Los Reyes, et al.
Human Gene Therapy
|
August 25, 2023
Positron Emission Tomography Quantitative Assessment of Off-Target Whole-Body Biodistribution of I-124-Labeled Adeno-Associated Virus Capsids Administered to Cerebral Spinal Fluid
Jonathan B Rosenberg, Edward K Fung, Jonathan P Dyke, et al.
Page
of 17